Safety of the use of gold nanoparticles conjugated with proinsulin peptide and administered by hollow microneedles as an immunotherapy in type 1 diabetes
使用与胰岛素原肽偶联的金纳米颗粒通过空心微针给药作为1型糖尿病免疫疗法的安全性
期刊:Immunotherapy Advances
影响因子:4.9
doi:10.1093/immadv/ltac002
Tatovic, D; McAteer, M A; Barry, J; Barrientos, A; Rodríguez Terradillos, K; Perera, I; Kochba, E; Levin, Y; Dul, M; Coulman, S A; Birchall, J C; von Ruhland, C; Howell, A; Stenson, R; Alhadj Ali, M; Luzio, S D; Dunseath, G; Cheung, W Y; Holland, G; May, K; Ingram, J R; Chowdhury, M M U; Wong, F S; Casas, R; Dayan, C; Ludvigsson, J